0 NYSE Companies - May 13, 2024Ducommun Incorporated Earns Northrop Grumman Missions Systems’ Platinum Supplier DesignationSANTA ANA, Calif., May 13, 2024 (GLOBE NEWSWIRE) — Ducommun Incorporated (NYSE: DCO) (“Ducommun” or the “Company”), a global supplier of […]Read More
0 NYSE Companies - May 13, 2024Parsons Celebrates 80 Years of Infrastructure ExcellenceCHANTILLY, Va., May 13, 2024 (GLOBE NEWSWIRE) — Parsons Corporation (NYSE: PSN) today celebrates Infrastructure Week, an annual event focused […]Read More
0 NASDAQ Companies - May 13, 2024AC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate UpdateAC Immune Reports First Quarter 2024 Financial Results and Provides a Corporate Update Landmark deal announced with Takeda for ACI-24.060 […]Read More
0 NASDAQ Companies - May 13, 2024Olink reports first quarter 2024 financial resultsUPPSALA, Sweden, May 13, 2024 (GLOBE NEWSWIRE) — Olink Holding AB (publ) (“Olink”) (Nasdaq: OLK) today announced its unaudited financial […]Read More
0 NASDAQ Companies - May 13, 2024Here’s a Crazy And Clever Marketing Idea: Clothes That Actually FitCANTON, Mass., May 13, 2024 (GLOBE NEWSWIRE) — Destination XL Group, Inc. (Nasdaq: DXLG), the largest integrated commerce specialty retailer […]Read More
0 NASDAQ Companies - May 13, 2024Fulcrum Therapeutics Enters into a Collaboration and License Agreement with Sanofi for the Development and Commercialization of Losmapimod in Facioscapulohumeral Muscular Dystrophy― Sanofi receives exclusive rights to commercialize losmapimod in all territories outside the U.S.; Fulcrum retains full U.S. commercialization rights […]Read More
0 NASDAQ Companies - May 13, 2024RadNet, Inc. to Present at the Bank of America Securities 2024 Health Care Conference on May 14th, 2024LOS ANGELES, May 13, 2024 (GLOBE NEWSWIRE) — RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective diagnostic […]Read More
0 NASDAQ Companies - May 13, 2024Fractyl Health Presents Clinical Update on Revita® German Real-World Registry for Patients With Advanced Type 2 Diabetes (T2D)First 14 participants with at least six months of follow up continue to demonstrate sustained improvements in blood glucose and […]Read More
0 NASDAQ Companies - May 13, 2024AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s DiseaseAC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease Takeda […]Read More
0 NASDAQ Companies - May 13, 2024WTW announces market first facility for cargo and war-on-land risks in UkraineLONDON, May 13, 2024 (GLOBE NEWSWIRE) — WTW (NASDAQ: WTW), a leading global advisory, broking and solutions company today announced […]Read More